PC
Pier Capital Portfolio holdings
AUM
$656M
This Quarter Return
-0.44%
1 Year Return
+27.51%
3 Year Return
+154.75%
5 Year Return
+238.14%
10 Year Return
+1,718.06%
AUM
$965M
AUM Growth
+$965M
(-3.2%)
Cap. Flow
-$22.5M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
14.62%
Holding
124
New
8
Increased
41
Reduced
62
Closed
5
Top Buys
| 1 |
Latham Group
SWIM
|
$7.97M |
| 2 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
$6.13M |
| 3 |
MaxCyte
MXCT
|
$5.97M |
| 4 |
Blend Labs
BLND
|
$5.89M |
| 5 |
ALX Oncology
ALXO
|
$5.57M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$10.9M |
| 2 |
RAVN
Raven Industries Inc
RAVN
|
$10.6M |
| 3 |
FIVE9
FIVN
|
$9.79M |
| 4 |
Sprout Social
SPT
|
$8.01M |
| 5 |
Papa John's
PZZA
|
$7.33M |
Sector Composition
| 1 | Technology | 29.52% |
| 2 | Healthcare | 23.27% |
| 3 | Industrials | 16.26% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Financials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
HealthEquity
HQY
$8.05B
| $7.21M | 0.75% |
111,281
-12,473
| -10% | -$808K |
|
77
TechTarget
TTGT
$405M
| $7.1M | 0.74% |
86,087
-39,672
| -32% | -$3.27M |
|
78
Alector
ALEC
$272M
| $7M | 0.72% |
306,536
-30,378
| -9% | -$693K |
|
79
Progyny
PGNY
$1.99B
| $6.93M | 0.72% |
123,769
-17,999
| -13% | -$1.01M |
|
80
Adaptive Biotechnologies
ADPT
$1.97B
| $6.71M | 0.7% |
197,492
-2,205
| -1% | -$75K |
|
|
MYOV
81
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.57M | 0.68% |
292,976
-7,640
| -3% | -$171K |
|
82
nLIGHT
LASR
$1.43B
| $6.37M | 0.66% |
225,958
-117,571
| -34% | -$3.31M |
|
83
Schrodinger
SDGR
$1.41B
| $6.26M | 0.65% |
114,489
+28,317
| +33% | +$1.55M |
|
84
DoubleVerify
DV
$2.62B
| $6.23M | 0.65% |
182,292
+40,518
| +29% | +$1.38M |
|
85
BioLife Solutions
BLFS
$1.19B
| $6.05M | 0.63% |
142,876
-2,269
| -2% | -$96K |
|
|
86
MaxCyte
MXCT
$143M
| $5.97M | 0.62% |
+488,673
| New | +$5.97M |
|
|
87
Blend Labs
BLND
$900M
| $5.89M | 0.61% |
+436,789
| New | +$5.89M |
|
88
Personalis
PSNL
$427M
| $5.83M | 0.6% |
302,786
-7,830
| -3% | -$151K |
|
89
CryoPort
CYRX
$422M
| $5.81M | 0.6% |
87,404
-102,942
| -54% | -$6.85M |
|
|
90
ALX Oncology
ALXO
$54.1M
| $5.57M | 0.58% |
+75,362
| New | +$5.57M |
|
91
Apellis Pharmaceuticals
APLS
$3.51B
| $5.14M | 0.53% |
+156,031
| New | +$5.14M |
|
92
LGI Homes
LGIH
$1.42B
| $5.09M | 0.53% |
35,878
+5,466
| +18% | +$776K |
|
93
Anavex Life Sciences
AVXL
$819M
| $4.96M | 0.51% |
+276,183
| New | +$4.96M |
|
94
Alphatec Holdings
ATEC
$2.31B
| $4.87M | 0.5% |
399,625
-273,151
| -41% | -$3.33M |
|
95
Installed Building Products
IBP
$7.17B
| $4.82M | 0.5% |
45,004
-45,860
| -50% | -$4.91M |
|
|
RVNC
96
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.62M | 0.48% |
165,913
-4,403
| -3% | -$123K |
|
|
VAPO
97
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $4.13M | 0.43% |
+185,300
| New | +$4.13M |
|
98
Immunocore
IMCR
$1.73B
| $2.91M | 0.3% |
+78,514
| New | +$2.91M |
|
99
Insulet
PODD
$23.9B
| $1.04M | 0.11% |
3,674
-1,452
| -28% | -$413K |
|
100
MSCI
MSCI
$42.6B
| $989K | 0.1% |
1,625
+776
| +91% | +$472K |
|